TSUYOSHI KOBAYASHI

Last Updated :2026/06/30

Affiliations, Positions
Graduate School of Biomedical and Health Sciences, Associate Professor
Web Site
E-mail
tsukobahiroshima-u.ac.jp
Self-introduction
I am conducting clinical and basic research with the aim of improving surgical outcomes for gastrointestinal cancers, particularly Hepato-Biliary-Pancreatic cancers.

Basic Information

Major Professional Backgrounds

  • 2020/06/01, Graduate School of Biomedical and Health Sciences, Gastroenterological and Transplant Surgery, Associate professor
  • 2015/10/01, Institute of Biomedical & Health Sciences, Department of Gastroenterological and Transplant Surgery, Lecturer
  • 2009/04/01, 2015/09/30, Hiroshima University Hospital, Assistant Professor
  • 2008/04/01, 2009/03/31, Hiroshima University Hospital, Clinical Fellow

Educational Backgrounds

  • Hiroshima University, Japan, 2006/03
  • Hiroshima University, Japan, 1996/03

Academic Degrees

  • Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Digestive surgery

Research Keywords

  • Hepato-Biliary-Pancreatic Surgery
  • Transplantation
  • cancer metastasis
  • gastroenterological cancer

Affiliated Academic Societies

  • Japan Surgical Society, 1996
  • The Japanese Society of Gastroenterological Surgery, 1996
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2007/11
  • The Japan Society of Hepatology, 2007/12
  • Japanese Liver Transplantation Society, 2020/04
  • The Japan Society for Transplantation, 2008
  • Japan Biliary Association, 2020/04
  • the Japan Society for Endoscopic Surgery, 2008
  • The Japanese Cancer Association, 2010

Educational Activity

Course in Charge

  1. 2026, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  3. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  4. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Gastroenterological and Transplant Surgery
  5. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Gastroenterological and Transplant Surgery

Research Activities

Academic Papers

  1. Identifying High-risk Patients with Synchronous Colorectal Liver Metastasis: Implications for Preoperative Chemotherapy Selection, JOURNAL OF THE ANUS RECTUM AND COLON, 10(2), 239-252, 2026
  2. Serum Bile Acids Are Useful Indicators of Intrahepatic Recurrence After Initial Curative Hepatectomy for Hepatocellular Carcinoma, ANNALS OF GASTROENTEROLOGICAL SURGERY, 10(3), 792-802, 202605
  3. Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer, JOURNAL OF GASTROENTEROLOGY, 61(4), 450-461, 202604
  4. Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver, JOURNAL OF HEPATOCELLULAR CARCINOMA, 13, 2026
  5. Risk factors of conversion to hand-assisted laparoscopic surgery or open surgery in laparoscopic liver resection: a multicenter prospective study (HiSCO-08), SCIENTIFIC REPORTS, 16(1), 20251226
  6. Efficacy of laparoscopic bailout surgery for moderate and severe acute cholecystitis, SCIENTIFIC REPORTS, 15(1), 20251229
  7. Outcomes of Liver Transplantation Among Patients Diagnosed With Acute-on-Chronic Liver Failure: A Single-Center Experience, TRANSPLANTATION PROCEEDINGS, 57(8), 1568-1573, 202510
  8. Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial (HiSCO-01), ANNALS OF GASTROENTEROLOGICAL SURGERY, 9(6), 1253-1262, 202511
  9. Clinical Significance of Circulating Tumor Cells in the Portal Vein of Patients with Hepatocellular Carcinoma Undergoing Anatomical Liver Resection, ANNALS OF SURGICAL ONCOLOGY, 32(13), 9561-9572, 202512
  10. Impact of SIRPα genotype combinations in recipients and donors on alloimmune response in liver transplantation, PNAS NEXUS, 4(11), 202511
  11. FIB-3 index as a novel age-independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy, ANNALS OF GASTROENTEROLOGICAL SURGERY, 9(5), 1055-1065, 202509
  12. Durvalumab induced immune-related agranulocytosis after conversion surgery in a patient with intrahepatic cholangiocarcinoma: a case report, FRONTIERS IN IMMUNOLOGY, 16, 20250711
  13. Usefulness of preoperative peripheral blood GPC3-positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study, HEPATOLOGY RESEARCH, 55(8), 1172-1183, 202508
  14. Coexistence of Median Arcuate Ligament Syndrome and Pancreatic Ductal Adenocarcinoma: A Case Report on Pancreaticoduodenectomy with Arterial Reconstruction, SURGICAL CASE REPORTS, 11(1), 2025
  15. Impacts of high mobility group box protein 1 gene polymorphisms on morbidity and mortality after living donor liver transplantation, TRANSPLANT IMMUNOLOGY, 90, 202505
  16. Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board-certified expert hepatobiliary and pancreatic surgeons and instructors, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 32(3), 179-193, 202503
  17. A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation, PLOS ONE, 20(1), 20250116
  18. Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study, JOURNAL OF GASTROINTESTINAL SURGERY, 29(4), 202504
  19. Multiomics Analysis of Liver Molecular Dysregulation Leading to Nonviral-Related Hepatocellular Carcinoma Development, JOURNAL OF PROTEOME RESEARCH, 24(3), 1102-1117, 20250221
  20. Albumin-Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology, ANNALS OF SURGICAL ONCOLOGY, 32(3), 1973-1984, 202503
  21. Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma, CANCER IMMUNOLOGY IMMUNOTHERAPY, 74(3), 20250204
  22. Sarcopenia's Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis, IN VIVO, 38(6), 2827-2835, 2024
  23. Effect of abdominal aortic calcification on long-term outcomes after the first liver resection in very old patients with hepatocellular carcinoma, ANNALS OF GASTROENTEROLOGICAL SURGERY, 9(1), 169-177, 202501
  24. The steatosis-associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma, ANNALS OF GASTROENTEROLOGICAL SURGERY, 9(1), 178-187, 202501
  25. Curative resection of multiple primary neuroendocrine tumors enabled by preoperative imaging: a case report, JOURNAL OF SURGICAL CASE REPORTS, 2025(1), 20250107
  26. Evaluation of prognostic efficacy of liver immune status index in predicting postoperative outcomes in hepatocellular carcinoma patients: A multi-institutional retrospective study, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 31(11), 798-808, 202411
  27. Laparoscopic resection for a case preoperatively diagnosed as adrenal rest tumor in the liver: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 124, 202411
  28. The Dominant Component and Clinicopathological Characteristics of Combined Hepatocellular-cholangiocarcinoma After Radical Resection, ANTICANCER RESEARCH, 44(10), 4551-4559, 202410
  29. Multicenter analysis of the efficacy of early cholecystectomy and preoperative cholecystostomy for severe acute cholecystitis: a retrospective study of data from the multi-institutional database of the Hiroshima Surgical Study Group of Clinical Oncology, BMC GASTROENTEROLOGY, 24(1), 20241001
  30. Effect of genetic polymorphisms of interleukin-1 beta on the microscopic portal vein invasion and prognosis of hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 31(8), 528-536, 202408
  31. Mucinous Cystic Neoplasm of the Liver in a Teenager: A Case Report, CUREUS JOURNAL OF MEDICAL SCIENCE, 16(7), 20240730
  32. Impact of a Liver Immune Status Index among Living Liver Transplant Recipients with Hepatocellular Carcinoma, JMA JOURNAL, 7(2), 232-239, 20240415
  33. A case of successful management for spontaneous rupture of paraganglioma treated with preoperative transcatheter arterial embolization, SURGICAL CASE REPORTS, 10(1), 20240621
  34. Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis, JOURNAL OF CLINICAL MEDICINE, 13(12), 202406
  35. Feasibility, safety, and efficacy of intraoperative magnetic resonance imaging-guided hepatectomy for small hepatocellular carcinoma: A retrospective study, PLOS ONE, 19(6), 20240628
  36. Comparison of postoperative outcomes in cases achieving sustained virological response with direct-acting antiviral and interferon therapy, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 31(5), 318-328, 202405
  37. Association of Abdominal Aortic Calcification With the Postoperative Metabolic Syndrome Components After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 56(3), 581-587, 202404
  38. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma, TRANSPLANTATION PROCEEDINGS, 56(3), 634-639, 202404
  39. The efficacy and safety of pure laparoscopic liver resection for hepatocellular carcinoma in super-elderly patients over 80 years: A multicenter propensity analysis, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 31(4), 234-242, 202404
  40. Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II, INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS, 28(1), 1-5, 2024
  41. Efficacy and safety of lenvatinib-transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study, BMJ OPEN, 13(10), 202310
  42. Outcomes and Prognostic Analysis of Surgical Resection for Oligometastasis from Hepatocellular Carcinoma, ANTICANCER RESEARCH, 43(11), 5189-5196, 202311
  43. Effect of Abdominal Aortic Calcification on Recurrence Following Initial Hepatectomy for Colorectal Liver Metastases, ANTICANCER RESEARCH, 44(2), 649-658, 202402
  44. Heterophile carbohydrate antigen N-glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma, CANCER REPORTS, 6(8), 202308
  45. Establishment of a cell culture platform for human liver organoids and its application for lipid metabolism research, BIOTECHNOLOGY JOURNAL, 19(1), 202401
  46. Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma, SURGERY TODAY, 54(2), 177-185, 202402
  47. Prospective Exploratory Phase I Clinical Trial Assessing the Safety of Preoperative Marking for Small Liver Tumors, CUREUS JOURNAL OF MEDICAL SCIENCE, 15(12), 20231215
  48. Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation, CANCERS, 16(3), 202402
  49. A Multicenter, Open-Label, Single-Arm Phase I Trial of Dual-Wield Parenchymal Transection: A New Technique of Liver Resection Using the Cavitron Ultrasonic Surgical Aspirator and Water- Jet Scalpel Simultaneously (HiSCO-14 Trial), CUREUS JOURNAL OF MEDICAL SCIENCE, 15(11), 20231118
  50. Preoperative percutaneous or transvascular marking for curative resection of small liver tumours with potential for missing during hepatectomy: a study protocol for an open-label, single-arm phase II study, BMJ OPEN, 13(10), 202310
  51. Impact of a new liver immune status index among patients with hepatocellular carcinoma after initial hepatectomy, ANNALS OF GASTROENTEROLOGICAL SURGERY, 7(6), 987-996, 202311
  52. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 30(8), 993-1005, 202308
  53. Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment, CANCERS, 15(17), 202309
  54. Prognosis of repeat hepatectomy for liver transplantable hepatocellular carcinoma recurrence after hepatectomy: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO), LANGENBECKS ARCHIVES OF SURGERY, 408(1), 20230816
  55. Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients, AMERICAN SURGEON, 89(4), 769-777, 202304
  56. Intracystic papillary neoplasm diagnosis following an extended cholecystectomy: a case report horizontal ellipsis and literature review, OXFORD MEDICAL CASE REPORTS, 2023(6), 20230601
  57. Impact of Abdominal Aortic Calcification on Chronic Kidney Disease After Liver Transplantation: A Retrospective Study, TRANSPLANTATION PROCEEDINGS, 55(4), 956-960, 202305
  58. Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 55(4), 906-912, 202305
  59. Impact of Geriatric Nutritional Risk Index After Initial Hepatectomy for Hepatocellular Carcinoma: a Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO), JOURNAL OF GASTROINTESTINAL SURGERY, 27(6), 1152-1158, 202306
  60. Surgery-related disseminated intravascular coagulation predicts postoperative complications, BMC SURGERY, 23(1), 20230411
  61. Efficacy of bailout surgery for preventing intraoperative biliary injury in acute cholecystitis, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 37(4), 2595-2603, 202304
  62. Impact of Abdominal Aortic Calcification After Major Hepatobiliary Pancreatic Surgery: A Retrospective Cohort Study, ANTICANCER RESEARCH, 42(12), 5983-5989, 202212
  63. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors, BMC CANCER, 22(1), 20221129
  64. Adoptive immunotherapy with natural killer cells from peripheral blood CD34(+) stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study, BMJ OPEN, 12(11), 202211
  65. Adoptive immunotherapy overcomes genetic susceptibility to bloodstream infections due to fc-gamma receptor polymorphisms after liver transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 22(10), 2392-2400, 202210
  66. The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma, INTERNATIONAL JOURNAL OF CANCER, 151(12), 2278-2290, 20221215
  67. Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients, Am Surg, 31348211041562-31348211041562, 20210830
  68. Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection, JOURNAL OF GASTROENTEROLOGY, 57(9), 676-683, 202209
  69. Downregulation of thrombomodulin contributes to ischemia-reperfusion injury in mice with steatotic liver, HEPATOLOGY RESEARCH, 52(9), 762-772, 202209
  70. Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology, SURGERY, 171(5), 1303-1310, 202205
  71. Metachronous colorectal liver metastasis that occurred 10 years after laparoscopic colectomy: a case report, SURGICAL CASE REPORTS, 8(1), 20220801
  72. Hepatic resection using intraoperative ultrasound and near-infrared imaging with indocyanine green fluorescence detects hepatic metastases from gastric cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 91, 202202
  73. Clostridium butyricum affects nutrition and immunology by modulating gut microbiota, BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 41(2), 30-36, 2022
  74. Successful Resection of Solitary Abdominal Wall Metastasis of Sarcomatous Intrahepatic Cholangiocarcinoma, CASE REPORTS IN GASTROENTEROLOGY, 13(1), 66-72, 2019
  75. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 29(3), 385-393, 202203
  76. ★, A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB (Oxford), 23(1), 134-143, 2021
  77. Validation of the Tokyo guideline 2018 treatment proposal for acute cholecystitis from a single-center retrospective analysis, ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 14(1), 14-20, 202101
  78. ★, A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB, 23(1), 134-143, 202101
  79. Induced hepatic stellate cell integrin, alpha 8 beta 1, enhances cellular contractility and TGF beta activity in liver fibrosis, JOURNAL OF PATHOLOGY, 253(4), 366-373, 202104
  80. Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer, EJSO, 47(3), 613-619, 202103
  81. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis, WORLD JOURNAL OF SURGICAL ONCOLOGY, 19(1), 20210405
  82. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients, BMC NEPHROLOGY, 22(1), 20210615
  83. ★, Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification, BMC CANCER, 21(1), 20210605
  84. Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy, MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 21, 171-179, 20210611
  85. Long-term survival by repeat resection for metastases from primary retroperitoneal leiomyosarcoma: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 82, 202105
  86. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib, INTERNAL MEDICINE, 60(13), 2047-2053, 2021
  87. Usefulness and safety of midline incision for right-sided hepatectomy: Cohort study, ANNALS OF MEDICINE AND SURGERY, 67, 202107
  88. Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review, CLINICAL CASE REPORTS, 8(1), 108-115, 202001
  89. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection, EUROPEAN JOURNAL OF RADIOLOGY, 124, 202003
  90. Simulation and navigation of living donor hepatectomy using a unique three-dimensional printed liver model with soft and transparent parenchyma, SURGERY TODAY, 50(3), 307-313, 202003
  91. Grade IV traumatic pancreatic injury with primary duodenum malignant lymphoma following pancreatoduodenectomy: a case report, SURGICAL CASE REPORTS, 6(1), 20200318
  92. Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report, CLINICAL JOURNAL OF GASTROENTEROLOGY, 13(3), 421-427, 202006
  93. Essential updates 2018/2019: Liver transplantation, ANNALS OF GASTROENTEROLOGICAL SURGERY, 4(3), 195-207, 202005
  94. Hemorrhoidectomy for elderly patients aged 75 years or more, before and after studies, ANNALS OF MEDICINE AND SURGERY, 55, 88-92, 202007
  95. Impact of systematic segmentectomy for small hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 27(6), 331-341, 202006
  96. ★, Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution, J Gastroenterol, 55(9), 877-887, 2020
  97. ★, Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma, J Hepatobiliary Pancreat Sci, 2020
  98. ★, PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study, Int J Surg, 80, 84-90, 2020
  99. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study, INTERNATIONAL JOURNAL OF SURGERY, 80, 84-90, 202008
  100. Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy, BMC GASTROENTEROLOGY, 20(1), 20200808
  101. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution, JOURNAL OF GASTROENTEROLOGY, 55(9), 877-887, 202009
  102. Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response, ONCOIMMUNOLOGY, 9(1), 2020
  103. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO), SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 34(11), 5055-5061, 202011
  104. Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery, SURGICAL CASE REPORTS, 6(1), 20201007
  105. Antithrombin attenuates the progression of hepatocellular carcinoma by regulating neutrophil/interleukin-8 signaling, HEPATOLOGY RESEARCH, 50(11), 1284-1296, 202011
  106. Identification of risk factors for open conversion from laparoscopic cholecystectomy for acute cholecystitis based on computed tomography findings, SURGERY TODAY, 50(12), 1657-1663, 202012
  107. Obliteration of a Portosystemic Shunt by Hybrid Interventional Radiology Using a Transmesenteric Approach Under Minilaparotomy After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(9), 2762-2766, 202011
  108. Impact on biliary complications of donor abdominal aortic calcification among living donor liver transplantation: a retrospective study, TRANSPLANT INTERNATIONAL, 33(12), 1745-1753, 202012
  109. De novo hepatocellular carcinoma in living donor liver grafts: A Japanese multicenter experience, HEPATOLOGY RESEARCH, 50(12), 1365-1374, 202012
  110. Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 27(12), 931-941, 202012
  111. Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection, BMC GASTROENTEROLOGY, 20(1), 20201007
  112. Impact of Abdominal Aortic Calcification Among Liver Transplantation Recipients, LIVER TRANSPLANTATION, 25(1), 79-87, 201901
  113. Antithrombin Insufficiency Promotes Susceptibility to Liver Tumorigenesis, JOURNAL OF SURGICAL RESEARCH, 236, 198-208, 201904
  114. ★, Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation, PLOS ONE, 14(3), 20190307
  115. Laparoscopic cholecystectomy for acute cholecystitis in a patient with left-sided gallbladder: a case report, SURGICAL CASE REPORTS, 5, 20190405
  116. ★, Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study, PLOS ONE, 14(5), 20190529
  117. Risk Factors for Refractory Ascites After Living Donor Liver Transplant, TRANSPLANTATION PROCEEDINGS, 51(5), 1516-1519, 201906
  118. Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience, JOURNAL OF GASTROENTEROLOGY, 54(7), 660-666, 201907
  119. Vitamin A-coupled liposomal Rho-kinase inhibitor ameliorates liver fibrosis without systemic adverse effects, HEPATOLOGY RESEARCH, 49(6), 663-675, 201906
  120. ★, Experience and outcomes in living donor liver procurement using the water jet scalpel, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 26(8), 370-376, 201908
  121. Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 51(6), 1934-1938, 2019
  122. Characteristics recurrence pattern of cholangiolocellular carcinoma as intrahepatic bile duct tumor growth following curative resection: a case report, SURGICAL CASE REPORTS, 5(1), 20190905
  123. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy, TRANSPLANTATION PROCEEDINGS, 51(8), 2740-2744, 201910
  124. ★, Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade, HEPATOLOGY RESEARCH, 49(10), 1218-1226, 201910
  125. Utility of Doppler Ultrasonography in Liver Transplantation With Celiac Axis Compression Syndrome: A Case Report, TRANSPLANTATION PROCEEDINGS, 51(9), 3103-3106, 201911
  126. Amputation neuroma derived from a remnant cystic duct 30 years after cholecystectomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 64, 184-187, 2019
  127. ★, Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma, ANNALS OF GASTROENTEROLOGICAL SURGERY, 3(6), 667-675, 201911
  128. Visceral Adipose Tissue and Skeletal Muscle Index Distribution Predicts Severe Pancreatic Fistula Development After Pancreaticoduodenectomy, ANTICANCER RESEARCH, 38(2), 1061-1066, 201802
  129. Utility of hepatobiliary scintigraphy for recurrent reflux cholangitis following choledochojejunostomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 42, 104-108, 2018
  130. A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 44, 131-134, 2018
  131. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis, ANNALS OF SURGICAL ONCOLOGY, 25(6), 1699-1708, 201806
  132. ★, Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 54, 156-162, 201806
  133. Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report, SURGICAL CASE REPORTS, 4, 2018
  134. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, 201808
  135. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 25(8), 370-376, 201808
  136. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study, INTERNATIONAL JOURNAL OF SURGERY, 57, 1-7, 201809
  137. Characteristics of the portal vein thrombosis recurrence pattern without liver parenchymal invasion from colorectal cancer: a case report, SURGICAL CASE REPORTS, 4, 2018
  138. Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis, ANNALS OF GASTROENTEROLOGICAL SURGERY, 2(5), 383-393, 201809
  139. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma, EJSO, 44(10), 1573-1579, 201810
  140. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates, TRANSPLANTATION PROCEEDINGS, 49(1), 98-101, 2017
  141. ★, Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 201701
  142. Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 31, 5-9, 2017
  143. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 39, 206-213, 201703
  144. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 201705
  145. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report, SURGICAL CASE REPORTS, 3, 20170525
  146. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 201707
  147. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 201707
  148. ★, Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study., Int J Surg., 44(44), 223-228, 2017
  149. ★, Application of endobronchial ultrasonography in laparoscopic liver segmentectomy in an animal model., Asian J Endosc Surg., 10(2), 209-212, 201705
  150. ★, Viability of Airborne Tumor Cells during Excision by Ultrasonic Device., Surg Res Pract., 2017
  151. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma (vol 41, pg 1860, 2017), WORLD JOURNAL OF SURGERY, 41(7), 1857-1859, 2017
  152. ★, Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 2017
  153. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma, ANTICANCER RESEARCH, 37(10), 5863-5870, 2017
  154. Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas, LANGENBECKS ARCHIVES OF SURGERY, 402(5), 745-755, 2017
  155. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: A retrospective cohort study, INTERNATIONAL JOURNAL OF SURGERY, 44, 223-228, 2017
  156. Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy, SURGERY TODAY, 47(10), 1230-1237, 2017
  157. ★, Prediction of recurrence following hepatectomy in patients with hepatitis C virus infection-related hepatocellular carcinoma who achieved a sustained virological response, HEPATOLOGY RESEARCH, 47(11), 1186-1195, 2017
  158. Propensity score-matching analysis of the efficacy of late cholecystectomy for acute cholecystitis, AMERICAN JOURNAL OF SURGERY, 214(2), 262-266, 2017
  159. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation, TRANSPLANT INFECTIOUS DISEASE, 19(5), 2017
  160. Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(11), 616-626, 2017
  161. Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 39, 29-33, 2017
  162. 3D printing model of the intrahepatic vessels for navigation during anatomical resection of hepatocellular carcinoma, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 41, 219-222, 2017
  163. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 24(1), 58-64, 2017
  164. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 2017
  165. Patients with early recurrence of hepatocellular carcinoma have poor prognosis, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16(3), 279-288, 2017
  166. Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma, WORLD JOURNAL OF SURGERY, 41(7), 1860-1870, 2017
  167. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection, HEPATOLOGY RESEARCH, 47(8), 767-772, 2017
  168. Periostin Promotes Malignant Potential by Induction of Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma, HEPATOLOGY COMMUNICATIONS, 1(10), 1099-1109, 201712
  169. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  170. An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 43-50, 2016
  171. The Incidence of Posthepatectomy Liver Failure Defined by the International Study Group of Liver Surgery among Living Donors, JOURNAL OF GASTROINTESTINAL SURGERY, 20(4), 757-764, 201604
  172. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  173. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  174. ★, h-prune affects anaplastic thyroid cancer invasion and metastasis, ONCOLOGY REPORTS, 35(6), 3445-3452, 201606
  175. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, 201606
  176. Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report, SURGICAL CASE REPORTS, 2, 20160317
  177. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, 201606
  178. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, 20160909
  179. Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder Carcinoma Outcomes Following Surgery with Curative Intent, ANTICANCER RESEARCH, 36(9), 4887-4894, 201609
  180. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter, Surg Case Rep, 2(1), 89, 201612
  181. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 201612
  182. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, 20161207
  183. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, DIGESTIVE SURGERY, 33(1), 8-14, 2016
  184. Radiopaque biodegradable stent for duct-to-duct biliary reconstruction in pigs, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 513-517, 2016
  185. ★, h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases, INTERNATIONAL JOURNAL OF CANCER, 139(4), 812-823, 2016
  186. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, 2016
  187. Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder Carcinoma Outcomes Following Surgery with Curative Intent, ANTICANCER RESEARCH, 36(9), 4887-4894, 2016
  188. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 2016
  189. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells, INTERNATIONAL JOURNAL OF CANCER, 136(4), E3-E13, 20150215
  190. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, 201501
  191. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, LANGENBECKS ARCHIVES OF SURGERY, 400(4), 471-476, 201505
  192. Administration of Antithrombin III Attenuates Posthepatectomy Liver Failure in Hepatocellular Carcinoma, DIGESTIVE SURGERY, 32(3), 173-180, 2015
  193. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, 201509
  194. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy, EJSO, 41(11), 1515-1521, 201511
  195. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 201510
  196. A case of biliary cystic tumor with repeated hemobilia, SURGICAL CASE REPORTS, 1, 2015
  197. Obstructive jaundice caused by a giant liver hemangioma with Kasabach-Merritt syndrome: a case report, SURGICAL CASE REPORTS, 1, 2015
  198. Pseudolymphoma of the liver: a case report and literature review, SURGICAL CASE REPORTS, 1, 2015
  199. Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats, LIVER TRANSPLANTATION, 21(1), 123-131, 2015
  200. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, 2015
  201. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 2015
  202. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, 201404
  203. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, 201404
  204. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 201412
  205. The Impact of Fc gamma Receptor Polymorphism on Infection-Related Complications in ABO-Incompatible Living Donor Liver Transplantation Under Rituximab-Based Immunosuppressive Regimen., LIVER TRANSPLANTATION, 20, S149-S149, 2014
  206. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 2014
  207. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, 201303
  208. ★, Prevention of recurrence after curative treatment for hepatocellular carcinoma, SURGERY TODAY, 43(12), 1347-1354, 201312
  209. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, 201304
  210. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, 20130806
  211. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, 20130627
  212. The impact of Fc gamma receptor polymorphisms on the outcome of ABO-incompatible living donor liver transplantation, XENOTRANSPLANTATION, 20(5), 322-322, 2013
  213. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, 2013
  214. Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case, SURGERY TODAY, 43(4), 418-423, 2013
  215. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, 2013
  216. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, 2013
  217. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, 201202
  218. A huge metastatic liver tumor from leiomyosarcoma of the inferior vena cava: report of a case, SURGERY TODAY, 42(5), 505-508, 201205
  219. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, 201201
  220. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, 201203
  221. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, 201203
  222. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, 20120527
  223. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, 201209
  224. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver, JOURNAL OF HEPATOLOGY, 56(1), 146-152, 2012
  225. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, 19(2), 418-425, 2012
  226. No Impact of Perioperative Blood Transfusion on Recurrence of Hepatocellular Carcinoma after Hepatectomy, WORLD JOURNAL OF SURGERY, 36(3), 651-658, 2012
  227. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, 2012
  228. Effects of canopy N uptake on foliar CO2 assimilation rates and biomass production and allocation in Japanese red pine seedlings, CANADIAN JOURNAL OF FOREST RESEARCH-REVUE CANADIENNE DE RECHERCHE FORESTIERE, 42(7), 1395-1403, 2012
  229. Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy, ANNALS OF SURGICAL ONCOLOGY, 19(9), 2888-2896, 2012
  230. ★, Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18(5), 689-699, 201109
  231. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  232. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child-Pugh Class B, WORLD JOURNAL OF SURGERY, 35(4), 834-841, 201104
  233. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, 20110701
  234. Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria, JOURNAL OF GASTROINTESTINAL SURGERY, 15(7), 1173-1181, 201107
  235. Involvement of myeloid derived suppressor cells (MDSC) in the changes of plasma amino acid profiles in cancer disease, CANCER RESEARCH, 71, 2011
  236. Splenectomy in Chronic Hepatic Disorders: Portal Vein Thrombosis and Improvement of Liver Function, DIGESTIVE SURGERY, 28(1), 9-14, 2011
  237. Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection, JOURNAL OF SURGICAL ONCOLOGY, 104(1), 3-9, 2011
  238. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, 2009
  239. Hepatectomy for Hepatocellular Carcinoma in Elderly Patients Aged 75 Years or More, JOURNAL OF GASTROINTESTINAL SURGERY, 13(4), 695-701, 2009
  240. Feasibility and Safety for Using Recipient's Middle Hepatic Vein for Drainage of the Right Paramedian Sector in Right Liver Graft, TRANSPLANTATION, 88(1), 144-145, 2009
  241. BACTERIAL AND FUNGAL INFECTIONS IN LIVING DONOR LIVER TRANSPLANTATION, TRANSPLANT INTERNATIONAL, 22, 202-202, 2009
  242. Role of double-balloon endoscopy in the diagnosis of small-bowel tumors: the first Japanese multicenter study, GASTROINTESTINAL ENDOSCOPY, 70(3), 498-504, 2009
  243. Suppression of Hepatocellular Carcinoma Recurrence After Rat Liver Transplantation by FTY720, a Sphingosine-1-Phosphate Analog, TRANSPLANTATION, 88(8), 980-986, 2009
  244. ★, Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions, Molecular and cellular biology, 26(3), 898-911, 20060101
  245. ★, A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial), SURGERY, 170(4), 1140-1150, 202110
  246. Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab, MEDICINE, 100(42), 20211022
  247. Treatment of multiple huge liver cysts in a hybrid operating room: a case report, SURGICAL CASE REPORTS, 7(1), 20211029
  248. Gradually progressive cholangiolocellular carcinoma: a case report, SURGICAL CASE REPORTS, 7(1), 20211220
  249. Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study, ANNALS OF GASTROENTEROLOGICAL SURGERY, 6(1), 149-158, 202201

Invited Lecture, Oral Presentation, Poster Presentation

  1. Initiatives and Significance of a Community-Based, Multicenter Collaborative Clinical Research Group, 2025/06/13, Without Invitation, Japanese
  2. Exploring prognostic biomarker and strategy for improving survival of hepatocellular carcinoma patients after living donor liver transplantation in Japan criteria, Naoki Tanimine, Masahiro Ohira, Yuki Imaoka, Hiroaki Mashima, Masakazu Hashimoto, Shintaro Kuroda, Hiroyuki Tahara, Tsuyoshi Kobayashi, Hideki Ohdan, 2022/06/10, Without Invitation, English
  3. Effect of Abdominal Aortic Calcification on Renal Function After Liver Transplantation, Ryuta Ide, Masahiro Ohira, Ryosuke Arata, Koki Imaoka, Keishi Hakoda, Kosuke Ono,Tetsuya Mochizuki, Naofumi Tsukiyama, Akhmet Seidakhmetov, Hiroaki Yamane, Koki Sato,Yuki Imaoka, Hiroaki Mashima, Doskali Marlen, Ryosuke Nakano, Masakazu Hashimoto, Naoki Tanimine, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Hideki Ohdan, American Transplant Congress 2022, 2022/06/04, Without Invitation, English, Boston
  4. Development of navigation surgery for liver tumors that are difficult to identify intraoperatively., Kuroda S, Kobayashi T, Okda K, Hashimoto M, Ohira M, Tahara H, Tanimine N, Ide K, Ohdan H, 2021/07/07, Without Invitation, English
  5. Navigation surgery for liver tumors that are difficult to identify intraoperatively, 2021/06/02, Without Invitation, English
  6. Selection of effective indications based on multicenter results of surgery for BCLC stage B and C hepatocellular carcinoma, M Yamamoto, T Kobayashi, A Oshita, T Abe, T Kohashi, T Onoe, S Fukuda, I Omori, Y Imaoka, N Honmyo, H Ohdan, 2021/02, Without Invitation, Japanese
  7. Challenge to prevent recurrence after surgical treatment for liver cancer, 2020/10/03, With Invitation, Japanese
  8. Anatomical liver resection using laparoscopy for single hepatocellular carcinoma, 2020/08, Without Invitation, Japanese
  9. Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO), Yamamoto M, Kobayashi T, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka T, Ohdan H, The 31st World Congress of the International Association of Surgeons, Gastroenterologist and Oncologists (IASGO), 2019/10/03, Without Invitation, English
  10. Safety and efficacy of novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites in liver transplant candidates, Sato K, Ohira M, Imaoka Y, Hashimoto S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H, 19th Congress of the European Society for Organ Transplantation, 2019/09/15, Without Invitation, English
  11. Significance and prospects of anatomical resection for hepatocellular carcinoma, 2019/07/19, Without Invitation, Japanese
  12. Management for refractory ascites after liver resection for hepatocellular carcinoma, 2019/07/18, Without Invitation, Japanese
  13. Significance of anatomical liver resection for intrahepatic recurrence of hepatocellular carcinoma, Tsuyoshi Kobayashi, Hiroaki Mashima, Shintaro Kuroda, Masateru Yamamoto, Megumi Yamaguchi, Naruhiko Honmyo, Sho Okimoto, Michinori Hamaoka, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Hideki Ohdan, 2019/06/14, Without Invitation, English
  14. Significance and safety of anatomical resection for hepatocellular carcinoma, 2019/06/14, Without Invitation, English
  15. SIRPa polymorphism modulates prognosis for Hepatocellular carcinoma, 2019/06/14, Without Invitation, English
  16. Clinicopathological characteristics of patients with combined hepatocellular carcinoma and cholangiocarcinoma, 2019/06/14, Without Invitation, English
  17. Strategy for the isolated bile duct injury after hepatectomy, 2019/06/13, Without Invitation, English
  18. A novel criteria for hepatectomy using posthepatectomy liver failure predictive model: the Volume-associated ICG-PLT-PT (VIPP) score, 2019/06/13, Without Invitation, English
  19. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for management of refractory ascites in liver transplant candidates, Sato K, Ohira M, Imaoka Y, Hashimoto S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H, 2019 American Transplant Congress, 2019/06/01, Without Invitation, Japanese
  20. Surgical strategy for the highly advanced hepatocellular carcinoma beyond BC LC classification, 2018/06/07, Without Invitation, Japanese
  21. Anatomical hepatectomy with the midline incision for right-sided liver tumors, Kobayashi T, Sho Okimoto, Shintaro Kuroda,Michinori Hamaoka,Seiichi Shimizu,Hiroyuki Tahara,Masahiro Ohira,Kentaro Ide,Kohei Ishiyama,Hideki Ohdan, the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association / the 29th Annual Congress of the Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2017/06/07, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. 2024/04/01, 2027/03/31
  2. 2018, 2020
  3. 2015
  4. KAKENHI, 2012, 2014
  5. KAKENHI, Development of the novel molecular targeted therapy against hepatocellular carcinoma invasion and metastasis, 2009, 2011

Social Activities

History as Peer Reviews of Academic Papers

  1. 2026, World Journal of Surgery, Others, 1
  2. 2025, Surgical Case Report, Others, 3
  3. 2025, Surg Today, Others, 1
  4. 2026, Signal Transduction & Targeted Therapy, Others, 2
  5. 2025, Liver International, Others, 1
  6. 2025, Journal of Hepato-Biliary-Pancreatic Sciences, Others, 2
  7. 2025, International Journal of Clinical Oncology, Others, 1
  8. 2025, Hepatol Res, Others, 1
  9. 2026, Hepatobiliary Surgery and Nutrition, Others, 1
  10. 2025, Cancer Medicine, Others, 1
  11. 2026, BMC Cancer, Others, 2
  12. 2026, Annals of Medicine, Others, 1
  13. 2025, World Journal of Surgical Oncology, Others, 1
  14. 2025, Discover Oncology, Others, 1
  15. 2025, BMC Gastroenterology, Others, 1
  16. 2025, Digestive Diseases and Sciences, Others, 1
  17. 2025, Scientific Reports, Others, 3
  18. 2025, Langenbeck's Archives of Surgery, Others, 1
  19. 2025, BMC Surgery, Others, 1
  20. 2025, BMC Cancer, Others, 5
  21. 2025, Annals of Gastroenterological Surgery, Others, 2
  22. 2025, Acta Chirurgica Belgica, Others, 1
  23. 2024, World Journal of Surgical Oncology, Others, 1
  24. 2024, Langenbeck's Archives of Surgery, Others, 2
  25. 2022, J Hepatobiliary Pancreat Sci, Others, reviewer, 1
  26. 2022, Hepatol Res, Others, reviewer, 1
  27. 2022, Surg Case Rep, Others, reviewer, 3
  28. 2022, J Gastroenterol, Others, reviewer, 2
  29. 2022, BMC gastroenterol, Others, reviewer, 1
  30. 2020, Transpl Int, Editor, 1
  31. 2021, Surg Case Rep, Editor, 1
  32. 2020, Surg Case Rep, Editor, 3
  33. 2019, Surg Case Rep, Editor, 1
  34. 2021, Surg Today, Editor, 1
  35. 2020, Surg Today, Editor, 5
  36. 2020, Sci Rep, Editor, 1
  37. 2020, PLoS One, Editor, 1
  38. 2020, Liver Int, Editor, 1
  39. 2020, Hepatol Res, Editor, 1
  40. 2020, Cancer Med, Editor, 3
  41. 2019, BMC Surg, Editor, 1
  42. 2019, BMC Surg, Editor, 1
  43. 2020, BMC Gastroenterol, Editor, 1
  44. 2020, BMC cancer, Editor, 1
  45. 2019, BMC cancer, Editor, 4
  46. 2019, Ann Surg Oncol, Editor, 1
  47. 2019, Am J Transplant, Editor, 1
  48. 2018, BMC Cancer, Editor, 1
  49. 2018, BMC Gastroenterol, Editor, 1
  50. 2018, Hepatol Res, Editor, 1
  51. 2018, Surg Case Rep, Editor, 1
  52. 2017, Hepatol Res, Editor, 2
  53. 2017, Oncotarget, Editor, 1
  54. 2016, Tumor Biology, Editor, 3
  55. 2016, World J Surg Oncol, Editor, 1
  56. 2016, Surg Case Rep, Editor, 3
  57. 2023, J Hepatobiliary Pancreat Sci, Others, reviewer, 1
  58. 2024, J Hepatobiliary Pancreat Sci, Others, reviewer, 1
  59. 2025, J Hepatobiliary Pancreat Sci, Others, reviewer, 1
  60. 2024, Hepatol Res, Others, reviewer, 2
  61. 2025, Hepatol Res, Others, reviewer, 1
  62. 2023, Surg Case Rep, Others, reviewer, 2
  63. 2024, Surg Case Rep, Others, reviewer, 1
  64. 2025, Surg Case Rep, Others, reviewer, 1
  65. 2024, BMC gastroenterol, Others, reviewer, 1
  66. 2025, BMC gastroenterol, Others, reviewer, 1
  67. 2024, BMC cancer, Others, reviewer, 2
  68. 2023, BMC cancer, Others, reviewer, 3
  69. 2023, BMC Surg, Others, reviewer, 1
  70. 2024, BMC Surg, Others, reviewer, 2
  71. 2024, Sci Rep, Others, 1
  72. 2025, Sci Rep, Others, 1